Medtech

Perkins Coie and Ashurst to merge into $2.7bn revenue firm
18 November 2025   The combination will create a firm with 3,000 lawyers across 52 offices—but a dive into its combined IP practice shows a heavy weighting in the US.

Latest Features

Biotechnology
Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.
Big Pharma
Revocation and infringement actions involving a cholesterol treatment, prosthetic valves, and methods for analyte detection are among the first to land at the court within its first month, explain Joanne Welch and Darren Smyth of EIP.
Medtech
More clarity is needed on the application of Alice and Mayo to patent eligibility—particularly for firms developing innovative medical diagnostic techniques, say Kara Specht and Yinan Liu of Finnegan.
Africa
Government-led schemes to incentivise patents are leading to delays and prejudice against legitimate applicants. Tyron Grant of Spoor and Fisher explains how South Africa is tackling the problem.
Medtech
Bringing a medical device to market relies on a broad understanding of IP, explain Sabing Lee and Kregg Koch of Knobbe Martens.
Big Pharma
Two decisions from the European Patent Office offer important guidance for healthcare inventions that use computers, says Rosie McDowell of EIP.
Medtech
A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.
Africa
The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy
All features


More News

1 September 2025   Non-practising entities are controversial, but political winds in the US are shifting and inventors, investors, and operating companies of all stripes should take note, writes Manny Caixeiro of Venable.
22 August 2025   The company has dismissed recent patent infringement claims from the Invisalign maker as “frivolous and entirely without merit,” pledging a vigorous defence.
21 August 2025   In a rare legal action, the medtech company claims the agency unlawfully let Apple reintroduce a feature on its watches that undermines an ITC ban.
21 August 2025   The $4 billion-a-year orthodontics company says its latest lawsuits defend “critical components” of its portfolio as rivals push cheaper alternatives.
18 August 2025   Several months after a US import ban sidelined a key Apple Watch feature, the tech giant is restoring a redesigned sensor to some models.
30 July 2025   The outcome of Apple’s smartwatch dispute at the Federal Circuit may provide important guidance for meeting the US’ threshold domestic industry requirement, write Nathan Mammen and Cole Tipton of Snell & Wilmer.
9 July 2025   California medical device company sues rival at the ITC and in Delaware court over “copycat” brain monitoring system launch in May | Ceribell accuses competitor of “a history of willful patent infringement”.
More news